Expression of CCL2 and CCR2 in the hippocampus and the interventional roles of propofol in rat cerebral ischemia/reperfusion

Experimental and Therapeutic Medicine

Volumn 8, Issue 2, 2014, Pages 657-661

  Guo, Yong Qing ^a   Zheng, Li Na ^a   Wei, Jian Feng ^a   Hou, Xiao Lai ^a   Yu, Shu Zhen ^a   Zhang, Wei Wei ^a   Jing, Jian Min ^a  

^a SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Cerebral ischemia reperfusion; Chemokine ligand 2; Chemokine receptor type 2; Hippocampus

Indexed keywords

CHEMOKINE RECEPTOR CCR2; FJ 261; MONOCYTE CHEMOTACTIC PROTEIN 1; PROPOFOL; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS ANALYSIS; BRAIN ISCHEMIA; CONTROLLED STUDY; DOWN REGULATION; HIPPOCAMPUS; MALE; MRNA EXPRESSION ASSAY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

EID: 84902578546     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1757     Document Type: Article

References (24)

1. Silbernagel G, Machann J, Häring HU, Fritsche A and Peter A: Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets. Eur J Clin Nutr 68: 97-100, 2014.
2. Hazalin NA, Lim SM, Cole AL, Majeed AB and Ramasamy K: Apoptosis induced by desmethyl-lasiodiplodin is associated with upregulation of apoptotic genes and downregulation of monocyte chemotactic protein-3. Anticancer Drugs 24: 852-861, 2013.
3. Shimizu S, Nakashima H, Karube K, Ohshima K and Egashira K: Monocyte chemoattractant protein-1 activates a regional Th1 immunoresponse in nephritis of MRL/lpr mice. Clin Exp Rheumatol 23: 239-242, 2005.
4. Chaturvedi LS, Zhang P and Basson MD: Effects of extracellular pressure and alcohol on the microglial response to inflammatory stimulation. Am J Surg 204: 602-606, 2012.
5. Volpe S, Cameroni E, Moepps B, et al: CCR2 acts as scavenger for CCL2 during monocyte chemotaxis. PLoS One 7: e37208, 2012.
6. Banisadr G, Gosselin RD, Mechighel P, et al: Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J Comp Neurol 492: 178-192, 2005.
7. Banisadr G, Gosselin RD, Mechighel P, et al: Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol 489: 275-292, 2005.
8. Foresti ML, Arisi GM, Katki K, et al: Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus. J Neuroinflammation 6: 40, 2009.
9. Harman F, Hasturk AE, Yaman M, et al: Neuroprotective effects of propofol, thiopental, etomidate, and midazolam in fetal rat brain in ischemia-reperfusion model. Childs Nerv Syst 28: 1055-1062, 2012.
10. McIntosh MP and Rajewski RA: Comparative canine pharmacokinetics-pharmacodynamics of fospropofol disodium injection, propofol emulsion, and cyclodextrin-enabled propofol solution following bolus parenteral administration. J Pharm Sci 101: 3547-3552, 2012.
11. Lee Y, Chung C and Oh YS: Effectiveness of propofol pretreatment on the extent of deranged cerebral mitochondrial oxidative enzyme system after incomplete forbrain ischemia/reperfusion in rats. J Korean Med Sci 15: 627-630, 2000.
12. Peters CE, Korcok J, Gelb AW and Wilson JX: Anesthetic concentrations of propofol protect against oxidative stress in primary astrocyte cultures: comparison with hypothermia. Anesthesiology 94: 313-321, 2001.
13. Tsuchiya M, Asada A, Maeda K, et al: Propofol versus midazolam regarding their antioxidant activities. Am J Respir Crit Care Med 163: 26-31, 2001.
14. Buggy DJ, Nicol B, Rowbotham DJ and Lambert DG: Effects of intravenous anesthetic agents on glutamate release: a role for GABAA receptor-mediated inhibition. Anesthesiology 92: 1067-1073, 2000.
15. Yu D, Jiang Y, Gao J, Liu B and Chen P: Repeated exposure to propofol potentiates neuroapoptosis and long-term behavioral deficits in neonatal rats. Neurosci Lett 534: 41-46, 2013.
16. Kobayashi M, Takeda Y, Taninishi H, et al: Quantitative evaluation of the neuroprotective effects of thiopental sodium, propofol, and halothane on brain ischemia in the gerbil: effects of the anesthetics on ischemic depolarization and extracellular glutamate concentration. J Neurosurg Anesthesiol 19: 171-178, 2007.
17. Cai J, Hu Y, Li W, et al: The neuroprotective effect of propofol against brain ischemia mediated by the glutamatergic signaling pathway in rats. Neurochem Res 36: 1724-1731, 2011.
18. Li J, Han B, Ma X and Qi S: The effects of propofol on hippocampal caspase-3 and Bcl-2 expression following forebrain ischemia-reperfusion in rats. Brain Res 1356: 11-23, 2010.
19. Ji K and Tsirka SE: Inflammation modulates expression of laminin in the central nervous system following ischemic injury. J Neuroinflammation 9: 159, 2012.
20. Murphy CA, Hoek RM, Wiekowski MT, Lira SA and Sedgwick JD: Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain. J Immunol 169: 7054-7062, 2002.
21. Babcock AA, Kuziel WA, Rivest S and Owens T: Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23: 7922-7930, 2003.
22. Yao Y and Tsirka SE: The CCL2-CCR2 system affects the progression and clearance of intracerebral hemorrhage. Glia 60: 908-918, 2012.
23. Andres RH, Choi R, Pendharkar AV, Gaeta X, Wang N, et al: The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke 42: 2923-2931, 2011.
24. Semple BD, Kossmann T and Morganti-Kossmann MC: Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab 30: 459-473, 2010.